Get started
Author

Yurika Nakayama

ORCID: 0009-0009-8302-8466
Observed ORCID: 0009-0009-8302-8466
OpenAlex ID: A5022742639
Nivolumab-induced acute demyelinating polyradiculoneuropathy mimicking Guillain-Barré syndrome
2018 · Takamasa Nukui, Yurika Nakayama, et al. · Journal of the Neurological Sciences · 34
CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer
2024 · Akira Ueda, Satoshi Yuki, et al. · Cancers · 11
Efficacy and Safety of Immune Checkpoint Inhibitor Combination Therapy for Dysphagia in Patients with Advanced Esophageal Cancer
2024 · Yurika Nakayama, Takayuki Ando, et al. · Journal of Clinical Medicine · 4
PDF
The Efficacy and Safety of Nivolumab Plus mFOLFOX6 in Gastric Cancer with Severe Peritoneal Metastasis
2024 · Yurika Nakayama, Takayuki Ando, et al. · Journal of Clinical Medicine · 4
PDF
Early-onset Colorectal Cancer in a Patient with Li-Fraumeni Syndrome: A Case Series and Literature Review
2025 · Kazuki Sekiguchi, Iori Motoo, et al. · Internal Medicine · 3
PDF
Prescription Pattern of Anamorelin; a Therapeutic Agent for Cancer Cachexia
2024 · Yoshihiro Tambo, Shinya Kajiura, et al. · Journal of Palliative Medicine · 2
Real-World Use of a Systemic Diclofenac Patch for Cancer Pain: A Retrospective Analysis of Prescription Patterns at a Single Japanese University Hospital
2026 · Shinya Kajiura, Shingo Chikaoka, et al. · Journal of Pain & Palliative Care Pharmacotherapy
CA125 kinetics as a marker for tumor progression during chemotherapy in patients with pancreatic cancer
2026 · Iori Motoo, Takayuki Ando, et al. · Scientific Reports
PDF
Comprehensive genomic profiling-guided treatment selection in appendiceal adenocarcinoma with discordant mismatch repair findings: a case report and literature review
2026 · Takayuki Ando, Yuki Tajiri, et al. · Research Square
PDF
Third-Line Treatment Timing After Second-Line Discontinuation in Advanced Pancreatic Cancer: A 30-Day Landmark Analysis
2026 · Kohei Nagata, Shinya Kajiura, et al. · Journal of Gastrointestinal Cancer
PDF
Three-month follow-up of high-dose intravenous iron monotherapy for cancer-related anemia in an ESA-free oncology setting: a real-world cohort study
2026 · Shinya Kajiura, Yudai Ishikawa, et al. · International Journal of Clinical Oncology
PDF
Three-Week Monitoring After Anamorelin Initiation in Unresectable or Recurrent Pancreatic Cancer: Dietary Intake Category, Observed Body Weight, and Prognostic Nutritional Index
2026 · Banri Ogino, Shinya Kajiura, et al. · Journal of Palliative Medicine
Characteristics and reasons for low-dose fentanyl patch use in opioid-naïve versus non-naïve patients with cancer pain
2026 · Shinya Kajiura, Shingo Chikaoka, et al. · Japanese Journal of Clinical Oncology
Clinical significance of serum CA125 kinetics as an early predictor of tumor progression in pancreatic cancer patients.
2026 · Iori Motoo, Takayuki Ando, et al. · Journal of Clinical Oncology
PDF
Peritoneal mesothelioma showing a remarkable response to nivolumab plus ipilimumab in a patient with Lynch syndrome: A case report and literature review
2026 · Yuko Ueda, Rei Fukuda, et al. · Internal Medicine
PDF
Naldemedine Initiation Timing after Oxycodone Start and Early Laxative Adjustment in Cancer Care: A Retrospective Cohort Study
2026 · Shinya Kajiura, Shingo Chikaoka, et al. · Palliative Medicine Reports
Focusing on clinical trial ineligibility: Nivolumab plus chemotherapy for patients with advanced gastric cancer.
2025 · Iori Motoo, Takayuki Ando, et al. · Journal of Clinical Oncology
Spontaneous regression of breast diffuse large B-cell lymphoma after needle biopsy
2018 · Yurika Nakayama · The Japanese Society of Hematology
The Characteristics of polyneuropathy induced by nivolumab
2018 · Yurika Nakayama · Japanese Society of Neurology
Works count: 19
Citation count: 58
H-index: 4
I10-index: 2
Year
Topic
Type